Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 6, 2010 - Issue
Submit an article Journal homepage
83
Views
12
CrossRef citations to date
0
Altmetric
Review

Emerging clinical role of ranolazine in the management of angina

David S VadnaisDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
&
Nanette K WengerDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USACorrespondence[email protected]
Pages 517-530 | Published online: 14 Oct 2010

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ashish K Gupta, David Winchester & Carl J Pepine. (2013) Antagonist molecules in the treatment of angina. Expert Opinion on Pharmacotherapy 14:17, pages 2323-2342.
Read now
Adriano AM Truffa, L Kristin Newby & Chiara Melloni. (2011) Extended-release ranolazine: critical evaluation of its use in stable angina. Vascular Health and Risk Management 7, pages 535-539.
Read now

Articles from other publishers (10)

Adriana Mares & Debabrata Mukherjee. (2020) Management of Chronic Total Occlusion of Coronary Artery. International Journal of Angiology 30:01, pages 048-052.
Crossref
Emmanuel Isaac, Stephanie M Cooper, Sandra A Jones & Mahmoud Loubani. (2020) Do age-associated changes of voltage-gated sodium channel isoforms expressed in the mammalian heart predispose the elderly to atrial fibrillation?. World Journal of Cardiology 12:4, pages 123-135.
Crossref
Harsh Agrawal, Richard A. Lange, Ruben Montanez, Soma Wali, Khan Omar Mohammad, Subrata Kar, Mohamed Teleb & Debabrata Mukherjee. (2019) The Role of Percutaneous Coronary Intervention in the Treatment of Chronic Total Occlusions: Rationale and Review of the Literature. Current Vascular Pharmacology 17:3, pages 278-290.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 279 284 .
Hua Ling, Kathleen A. Packard, Tammy L. Burns & Daniel E. Hilleman. (2013) Impact of Ranolazine on Clinical Outcomes and Healthcare Resource Utilization in Patients with Refractory Angina Pectoris. American Journal of Cardiovascular Drugs 13:6, pages 407-412.
Crossref
Sridharan Rajamani, John C. Shryock & Luiz Belardinelli. 2013. Electrical Diseases of the Heart. Electrical Diseases of the Heart 177 191 .
Peter Greaves. 2012. Histopathology of Preclinical Toxicity Studies. Histopathology of Preclinical Toxicity Studies 263 324 .
Jean-Louis Gayet, Franck Paganelli & Alain Cohen-Solal. (2011) Update on the medical treatment of stable angina. Archives of Cardiovascular Diseases 104:10, pages 536-544.
Crossref
Jonathon R. Green, Gilbert J. Diaz, James T. Limberis, Kathryn A. Houseman, Zhi Su, Ruth L. Martin, Bryan F. Cox, Stan Kantor & Gary A. Gintant. (2011) Ventricular rate adaptation: A novel, rapid, cellular-based in-vitro assay to identify proarrhythmic and torsadogenic compounds. Journal of Pharmacological and Toxicological Methods 64:1, pages 68-73.
Crossref
V. Lionetti, W. C. Stanley & F. A. Recchia. (2011) Modulating fatty acid oxidation in heart failure. Cardiovascular Research 90:2, pages 202-209.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.